FilingReader Intelligence

Intco Medical grants restricted stock, adjusts convertible bond price

July 18, 2025 at 05:28 PM UTC•By FilingReader AI

Intco Medical completed its 2025 restricted stock grant, registering 12.8 million shares at 11.30 yuan per share for 1,077 participants. This diluted the controlling shareholder's stake from 36.10% to 35.39%.

The company's convertible bond conversion price was adjusted from 3.26 yuan to 3.42 yuan per share due to the share increase.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

Announcement regarding the completion of registration for the initial grant portion of the company's 2025 restricted stock incentive plan and the change in equity interest of the controlling shareholder and actual controller reaching 1%July 18, 2025 at 08:00 AM UTC

Supplementary Source Documents

Announcement on the completion of the initial grant registration for the 2025 restricted stock incentive plan and the adjustment of the Inke convertible bond conversion priceJuly 18, 2025 at 08:00 AM UTC

Intco Medical Technology

SZSE:300677•Shenzhen Stock Exchange

RSS feed for Intco Medical Technology

News Alerts

Get instant email alerts when Intco Medical Technology publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →